Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
25.00
+2.33 (10.28%)
Dec 19, 2025, 3:02 PM EST - Market open
Pelthos Therapeutics Employees
As of December 31, 2024, Pelthos Therapeutics had 11 total employees, including 4 full-time and 7 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
$673,273
Profits / Employee
-$2,143,758
Market Cap
77.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 3 | 37.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTHS News
- 17 days ago - Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely - Seeking Alpha
- 5 weeks ago - Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing - GlobeNewsWire
- 6 weeks ago - Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 - GlobeNewsWire
- 3 months ago - Pelthos Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 4 months ago - Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update - GlobeNewsWire